BIO Letter to Secretary Mayorkas on International Entrepreneur Rule
February 5, 2021
We encourage you to formally withdraw the proposed rule from the previous administration to remove IER, and to fully implement IER for the first time. The International Entrepreneur Rule would allow world-class foreign entrepreneurs to launch high-growth companies in the United States by utilizing the parole authority of the Department of Homeland Security (DHS). Unfortunately, the Trump Administration repeatedly sought to remove IER and block implementation before the program launched, thereby costing the United States jobs and innovation that are needed for our country to recover from the effects of the COVID-19 pandemic.
Download Full Comments Below
BIO Letter to Secretary Mayorkas on International Entrepreneur Rule
Dear Colleagues,This month marks my one-year anniversary as BIO’s CEO. Like most of us in biotech, this post has been a labor of love. At no time in my 25-year career in this industry have I ever witnessed such awe-inspiring science. Today, we…
Re: BIO Comments on Office of Management and Budget (OMB) Statistical Policy Directive No. 8 North American Industry Classification System (NAICS)-Request forComments on Possible Revisions for 2027 (USBC–2024–0032)Dear Ms. Orvis,The Biotechnology…
Under the 340B program, participating manufacturers must offer 340B pricing on their covered outpatient drugs by covered entities, as a condition of having those drugs federally payable under Medicare Part B and Medicaid. Critically, Congress…
We encourage you to formally withdraw the proposed rule from the previous administration to remove IER, and to fully implement IER for the first time. The International Entrepreneur Rule would allow world-class foreign entrepreneurs to launch high-growth companies in the United States by utilizing the parole authority of the Department of Homeland Security (DHS). Unfortunately, the Trump Administration repeatedly sought to remove IER and block implementation before the program launched, thereby costing the United States jobs and innovation that are needed for our country to recover from the effects of the COVID-19 pandemic.